Literature DB >> 10871547

Detection of PrP in extraneural tissues.

K L Brown1, D L Ritchie, P A McBride, M E Bruce.   

Abstract

Transmissible spongiform encephalopathies (TSEs) or "prion diseases" are a group of unconventional fatal diseases. TSEs are characterised by the accumulation of a modified form of the normal host glycoprotein, PrP (PrP(c)). In the course of infection PrP(c) is converted to an abnormally protease resistant form, PrP(Sc). The exact nature of the infectious agent responsible for these diseases remains controversial. While there is compelling evidence that TSE agents contain an informational molecule, possibly a nucleic acid, some believe that the infectious agent or "prion" is solely composed of PrP(Sc). Nevertheless, PrP is required for TSE pathogenesis, as mice devoid of the PrP gene (PrP(-/-)) remain healthy when challenged with TSE isolates and are unable to replicate infectivity within the central nervous system (CNS) or in other tissues. In recent years immunocytochemistry has been used to pinpoint which cells are associated with abnormal accumulations of PrP, providing important information on the cellular targeting of TSE infection. In uninfected and scrapie-infected mice, PrP protein is found in the CNS and in extraneural tissues such as spleen and lymph nodes. In the peripheral lymphoid system, PrP is associated with follicular dendritic cells that are known to be important for replication of infectivity for at least one TSE strain. This review will focus on current methods for the immunocytochemical detection of PrP in murine extraneural tissues, mainly lymphoid tissues, and will discuss recent findings on the role of the peripheral lymphoid system in TSE pathogenesis. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871547     DOI: 10.1002/1097-0029(20000701)50:1<40::AID-JEMT7>3.0.CO;2-M

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  13 in total

1.  The normal cellular prion protein (PrPc) is strongly expressed in bovine endocrine pancreas.

Authors:  W M Amselgruber; M Büttner; T Schlegel; M Schweiger; E Pfaff
Journal:  Histochem Cell Biol       Date:  2005-10-06       Impact factor: 4.304

2.  Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Takayuki Fuse; Takehiro Nakagaki; Naohiro Yamaguchi; Katsuya Satoh; Kenya Honda; Noriyuki Nishida
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Could immunomodulation be used to prevent prion diseases?

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

4.  Pathogenesis of chronic wasting disease in cervidized transgenic mice.

Authors:  Davis M Seelig; Gary L Mason; Glenn C Telling; Edward A Hoover
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

5.  Resistance of neonatal mice to scrapie is associated with inefficient infection of the immature spleen.

Authors:  Michelle Ierna; Christine F Farquhar; George W Outram; Moira E Bruce
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 6.  Immunomodulation for prion and prion-related diseases.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

7.  High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice.

Authors:  F Goñi; F Prelli; F Schreiber; H Scholtzova; E Chung; R Kascsak; D R Brown; E M Sigurdsson; J A Chabalgoity; T Wisniewski
Journal:  Neuroscience       Date:  2008-03-06       Impact factor: 3.590

8.  Prion protein accumulation and neuroprotection in hypoxic brain damage.

Authors:  Neil F McLennan; Paul M Brennan; Alisdair McNeill; Ioan Davies; Andrew Fotheringham; Kathleen A Rennison; Diane Ritchie; Francis Brannan; Mark W Head; James W Ironside; Alun Williams; Jeanne E Bell
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 9.  The diverse roles of mononuclear phagocytes in prion disease pathogenesis.

Authors:  Gwennaelle J Wathne; Neil A Mabbott
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

10.  Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay.

Authors:  Yervand Eduard Karapetyan; Paula Saá; Sukhvir Paul Mahal; Gian Franco Sferrazza; Alexandra Sherman; Nicole Salès; Charles Weissmann; Corinne Ida Lasmézas
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.